Product information

Current status:

Cancelled Post Market

Current status date:

2007-06-27

Original market date: ^{See footnote 1}

1997-01-17

Product name:

BREVIBLOC INJECTION 250MG/ML

DIN:

02188864 Electronic product monograph is not available

Company:

BAXTER CORPORATION
7125 Mississauga Road
Mississauga
Ontario
Canada L5N 0C2

Class:

Human

Dosage form(s):

Liquid

Route(s) of administration:

Intravenous

Number of active ingredient(s):

1

Schedule(s):

Prescription

American Hospital Formulary Service (AHFS): ^{See footnote 3}

24:24.00 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

C07AB09 ESMOLOL

Active ingredient group (AIG) number:^{See footnote5}

0123418002